Found: 6
Select item for more details and to access through your institution.
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. N.PAG, doi. 10.15252/emmm.201910666
- By:
- Publication type:
- Article
Targeting key angiogenic pathways with a bispecific Cross MAb optimized for neovascular eye diseases.
- Published in:
- EMBO Molecular Medicine, 2017, v. 9, n. 7, p. 985, doi. 10.15252/emmm.201707895
- By:
- Publication type:
- Article
Targeting key angiogenic pathways with a bispecific Cross MAb optimized for neovascular eye diseases.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 11, p. 1265, doi. 10.15252/emmm.201505889
- By:
- Publication type:
- Article
HTRA1 Regulates Subclinical Inflammation and Activates Proangiogenic Response in the Retina and Choroid.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810206
- By:
- Publication type:
- Article
Gene-Based Therapeutics for Inherited Retinal Diseases.
- Published in:
- Frontiers in Genetics, 2022, v. 12, p. 1, doi. 10.3389/fgene.2021.794805
- By:
- Publication type:
- Article
Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.795010
- By:
- Publication type:
- Article